The US Food and Drug Administration has asked Johnson & Johnson to discard 60 million doses of its Covid-19 vaccine manufactured at the problem-plagued Baltimore factory, Reuters quoted the New York Times as saying.

A further 10 million J&J doses would be allowed to be distributed with a warning that there was no guarantee contract manufacturer Emergent BioSolutions Inc had followed proper practices, the newspaper said.

The FDA said in a news release that it had agreed that two batches of the vaccine were authorised for use, but that multiple other batches were not suitable for use and that others were being evaluated.

Opinion

Editorial

Budget presser
14 Jun, 2026

Budget presser

OFFICIAL post-budget media briefings in Pakistan are carefully choreographed affairs, full of reassuring phrases ...
Muharram precautions
14 Jun, 2026

Muharram precautions

WITH Muharram due to start next week, the authorities have already begun annual exercises to ensure that the ...
Blood bequests
14 Jun, 2026

Blood bequests

WORLD Blood Donor Day offers a moment of “gratitude, advocacy and renewed commitment” for thalassaemia patients...
Sustainable path?
Updated 13 Jun, 2026

Sustainable path?

The FY27 budget is the first clear signal that the government is ready to transition from stabilisation to growth.
Prioritising education
13 Jun, 2026

Prioritising education

THOUGH the improvement in the country’s literacy rate may be slight, as highlighted by the Economic Survey, it ...
Poverty’s rise
13 Jun, 2026

Poverty’s rise

AS attention turns to the government’s plans for the coming fiscal year, one set of figures deserves particular...